IRIS
SORRENTINO, Dario Rosario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.739
AS - Asia 3.424
EU - Europa 2.458
SA - Sud America 637
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 3
Totale 16.328
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.646
SG - Singapore 1.710
CN - Cina 805
UA - Ucraina 780
BR - Brasile 531
DE - Germania 521
HK - Hong Kong 360
FI - Finlandia 323
VN - Vietnam 225
SE - Svezia 189
RU - Federazione Russa 175
IE - Irlanda 141
IT - Italia 134
TR - Turchia 97
GB - Regno Unito 65
CA - Canada 61
IN - India 60
AR - Argentina 42
FR - Francia 37
KR - Corea 37
NL - Olanda 25
BD - Bangladesh 23
PL - Polonia 18
EC - Ecuador 17
MX - Messico 17
IR - Iran 16
ID - Indonesia 14
BE - Belgio 13
CO - Colombia 13
ZA - Sudafrica 12
IQ - Iraq 11
CL - Cile 10
EU - Europa 10
JP - Giappone 10
VE - Venezuela 10
KE - Kenya 9
ES - Italia 8
TN - Tunisia 8
AT - Austria 7
EG - Egitto 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
MA - Marocco 6
PY - Paraguay 6
PE - Perù 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
CH - Svizzera 4
IL - Israele 4
JO - Giordania 4
AL - Albania 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
SA - Arabia Saudita 3
BB - Barbados 2
BW - Botswana 2
ET - Etiopia 2
JM - Giamaica 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
PT - Portogallo 2
QA - Qatar 2
SN - Senegal 2
UY - Uruguay 2
AD - Andorra 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CU - Cuba 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GN - Guinea 1
GR - Grecia 1
GY - Guiana 1
KI - Kiribati 1
KW - Kuwait 1
LC - Santa Lucia 1
LV - Lettonia 1
MG - Madagascar 1
MK - Macedonia 1
MY - Malesia 1
MZ - Mozambico 1
OM - Oman 1
PG - Papua Nuova Guinea 1
PH - Filippine 1
PS - Palestinian Territory 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 16.324
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.394
Fairfield 1.206
Houston 821
Ashburn 674
Singapore 654
Ann Arbor 640
Seattle 506
Jacksonville 499
Chandler 496
Wilmington 467
Dearborn 417
Cambridge 406
Beijing 399
Hong Kong 359
Munich 202
Boardman 186
Princeton 146
Dublin 140
Helsinki 103
Izmir 86
Los Angeles 80
Hefei 72
San Diego 69
Buffalo 63
Roanoke 61
Ho Chi Minh City 58
Dallas 54
Udine 54
Des Moines 43
Hanoi 43
Nanjing 39
Redondo Beach 39
São Paulo 37
Dong Ket 36
Seoul 35
Kunming 30
Ottawa 29
Norwalk 28
Ogden 28
New York 25
Jinan 24
Mumbai 24
Rio de Janeiro 20
Guangzhou 19
Warsaw 17
Curitiba 16
Nanchang 15
Redmond 15
Toronto 15
Torre Del Greco 13
Turku 13
Andover 12
Brussels 12
Campinas 12
Falls Church 12
Thái Bình 12
Belo Horizonte 11
Grafing 11
Haiphong 11
Brasília 10
Atlanta 9
Milan 9
Montreal 9
Orem 9
Phoenix 9
Redwood City 9
Brooklyn 8
Chennai 8
Guayaquil 8
Moscow 8
Nairobi 8
Porto Alegre 8
Santa Clara 8
Tokyo 8
Boston 7
Fuzhou 7
Rosendaal 7
Salvador 7
Simi Valley 7
Stockholm 7
Ankara 6
Biên Hòa 6
Changsha 6
Chicago 6
Dhaka 6
Goiânia 6
Johannesburg 6
Jyväskylä 6
Leawood 6
Monmouth Junction 6
Nuremberg 6
Quito 6
Quzhou 6
Shenyang 6
Shenzhen 6
Washington 6
Wuhan 6
Betim 5
Cairo 5
Chengdu 5
Totale 11.295
Salva come PNG Salva come JPEG
Nome #
Gastric B-cell clonal expansion and Helicobacter pylori infection in patients with autoimmune diseases and with dyspepsia. A follow-up study. 301
Mechanisms of cellular uptake of free fatty acids 251
Letter: when to withhold anti-TNF agents prior to abdominal surgery in patients with Crohn's disease—the jury might still be out 213
Cavernous transformation of the portal vein associated to multiorgan developmental abnormalities 207
B-cell clonal expansion in gastric biopsies of patients with dyspepsia and autoimmune diseases: effect of H. Pylori eradication. 189
"Albumin Receptor" uptake kinetics do not require an intact lobular architecture and are not specific for albumin 175
Bringing Top-End Endoscopy to Regional Australia: Hurdles and Benefits 174
At physiologic albumin:oleate concentrations oleate uptake by isolated hepatocytes, adipocytes and cardiac myocytes is a saturable function of unbound oleate concentrations. Uptake kinetics are consistent with the conventional theory 168
Infliximab in Crohn's disease: a look at the (not so distant) future. 163
Acute severe colitis: infliximab and/or cyclosporine? 160
Functional and morphological features of isolated hepatocytes preserved in University of Wisconsin solution. 160
B-cell clonality and infection with Helicobacter pylori: implications for development of gastric lymphoma 158
Postoperative recurrence of Crohn's disease: the beginning of the end? 158
Phenobarbital specifically increases the hepatocellular uptake of sulfobromophthalein-glutathione. 158
Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet 157
Prevention of postoperative recurrence of Crohn's disease: does the type of surgery matter? 157
Transferrin metabolism in alcoholic liver disease. 157
B cell clonality in gastric lymphoid tissues of patients with Sjogren's syndrome 156
Hepatocellular fatty acid uptake is mediated by a plasma membrane fatty acid binding protein closely related to mitochondrial glutamic oxaloacetic transaminase. 155
Anti-TNFs for prevention of postoperative recurrence of Crohn's disease: a broken record? 155
Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn's disease 155
Anti-TNF's for Postoperative Recurrence in Crohn's Disease: The If's and How's 154
Ustekinumab as induction and maintenance therapy for ulcerative colitis 150
Bile acid secretion and pool size during phenobarbital-induced hypercholeresis 149
Hepatocellular 22Na+ uptake: effect-of-oleate 148
Surgery for Crohn's disease and anti-TNF agents. The changing scenario 148
Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren's syndrome 148
Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease 148
Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus 147
The hepatocellular transport of sulfobromophthalein-glutathione by clofibrate treated, perfused rat liver 144
Uptake of oleate by isolated rat adipocytes is mediated by a 40 kDa plasma membrane fatty acid binding protein closely related to that in liver and gut 144
Diagnosis and assessment of Crohn's disease: the present and the future 144
Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease. 144
Low dose infliximab for prevention of postoperative recurrence of crohn's disease: Long term follow-up and impact of infliximab trough levels and antibodies to infliximab 143
An increased Bax/Bcl-2 ratio in circulating inflammatory cells predicts primary response to infliximab in inflammatory bowel disease patients 143
The race for mainstream gastrointestinal endoscopy: frontrunners. 142
Hepatic disposition of clinically useful 5-nitrofurans 142
Oleate uptake by isolated hepatocytes and the perfused rat liver is competitively inhibited by palmitate 142
Impact of Diagnostic Delay and Associated Factors on Clinical Outcomes in a U.S. Inflammatory Bowel Disease Cohort 142
Internet use among inflammatory bowel disease patients: an Italian multicenter survey. 141
The role of magnetic resonance imaging in detecting intestinal fibrosis in Crohn's disease. 140
"Cervia II Working Group Report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy 139
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease after Ileocolonic Resection 139
Fibrocytes, Inflammation, and Fibrosis in Crohn's Disease: Another Piece of the Puzzle. 138
Mechanistic aspects of hepatic bilirubin uptake 138
Adipocyte differentiation of 3T3-L1 cells involves augmented expression of a 43 kDa plasma membrane fatty acid binding protein 137
B-cell clonality in gastric mucosa of patients with Sjögren's syndrome and connective tissue diseases: relationship with Helicobacter pylori, EBV and human herpesvirus-6 (HHV-6) infections. 136
Ustekinumab as induction and maintenance therapy for Crohn's disease 134
Plasma membrane fatty acid-binding protein and mitochondrial glutamic-oxaloacetic transaminase of rat liver are related 134
Prevention of postoperative recurrence of Crohn's disease by infliximab 134
Isolated Bilateral Gastrocnemius Myositis in Crohn Disease Successfully Treated with Adalimumab 132
Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease 131
Medical prevention of postoperative recurrence of Crohn’s Disease: The state of the art 130
Isolation and partial characterization of plasma membrane fatty acid binding proteins from myocardium and adipose tissue and their relationship to analogous proteins in liver and gut 130
Sex differences in hepatic fatty acid uptake reflect a greater affinity of the transport system in females 130
Transmembrane TNF-α density, but not soluble TNF-α level, is associated with primary response to infliximab in inflammatory bowel disease 129
Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis 128
Ustekinumab induction and maintenance therapy in refractory Crohn's disease. 127
Long-term prevention of postoperative Crohn's disease recurrence with azathioprine: the wolf in the sheep clothing. 127
B-CELL CLONAL EXPANSION IN GASTRIC BIOPSIES OF PATIENTS WITH DYSPEPSIA AND AUTOIMMUNE-DISEASES - EFFECT OF HELICOBACTER-PYLORI ERADICATION 126
Unbound ligand drives hepatocyte taurocholate and BSP uptake at physiological albumin concentration 126
Therapeutic Targets in Inflammatory Bowel Disease: Are We Getting the Point Across? 126
The hepatocellular uptake of free fatty acids is selectively preserved during starvation 124
Microbial dysbiosis in spouses of ulcerative colitis patients: Any clues to disease pathogenesis? 124
Esophageal ulceration due to alendronate 123
Role of biologics and other therapies in stricturing Crohn's disease: what have we learnt so far? 123
Diagnostic and Therapeutic Delays in the Management of Postoperative Crohn's Disease 122
Characteristics of oleate binding to liver plasma membranes and its uptake by isolated hepatocytes 122
Heart-touching Chilaiditi's syndrome 121
Organic anion-transporting polypeptides: expression cloning and functional tests 121
Quantitation of plasma membrane fatty acid binding protein by enzyme dilution and monoclonal antibody based immunoassay 120
235) La terapia con Infliximab più Metotrexate a basse dosi nella prevenzione delle recidive post-chirurgiche del Morbo diCrohn 120
Colonic sarcoidosis, infliximab, and tuberculosis: a cautionary tale 120
Early Diagnosis and Treatment of Postoperative Endoscopic Recurrence of Crohn's Disease: Partial Benefit by Infliximab-A Pilot Study 120
Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents 120
Scientific publications in gastroenterology and hepatology in Western Europe, USA and Japan in the years 1992-1996: a global survey 119
Familial hyperbilirubinaemia syndromes: kinetic approaches 118
The hepatocellular uptake of bilirubin: current concepts and controversies. 115
Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: an expert consensus report. 114
Oleate uptake kinetics in the perfused rat liver are consistent with pseudofacilitation by albumin 114
Capturing the Biologic Onset of Inflammatory Bowel Diseases: Impact on Translational and Clinical Science 114
Clinical remission after stopping infliximab in Crohn's disease: is all that glitters true gold? 113
Utility of fecal markers to diagnose and monitor inflammatory bowel diseases 113
Small Bowel Inflammation in Crohn's Disease and Other Conditions 113
Helicobacter pylori infection and autoimmune processes: an emerging field of study. 112
Continuous monitoring of the biliary excretion of a pulse of labeled compounds 112
Characterization of prelymphomatous stages of lymphoproliferation in Sjögren’s syndrome. 111
Clinically Significant Small Bowel Crohn's Disease Might Only be Detected by Capsule Endoscopy 110
MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's disease of the terminal ileum 110
Gastric B-cell clonal expansion and hepatitis C virus infection: a study in patients with Sjögren’s syndrome. 108
Unexplained Symptoms and Hidden Inflammation in Patients With Crohn's Disease 108
Hepatocellular sulfobromophthalein uptake at physiologic albumin concentrations: Kinetic evidence for a high affinity/low capacity sinusoidal membrane system 106
Fibrotic strictures and anti-TNF-alpha therapy in Crohn's disease 104
Hepatitis C virus infection and gastric lymphoproliferation in patients with Sjögren's syndrome 103
Gastric lymphoid follicles: prevalence in patients with dyspepsia and with autoimmune diseases and relationship with Helicobacter pylori infection. Gastroenterology 100
From albumin to the cytoplasm: the hepatic uptake of organic anions 100
The Coming of Age of Inflammatory Bowel Diseases in Asia 98
Low-dose biologics to treat inflammatory bowel disease. Ready for prime time? 98
MR of small bowel in patients with Crohn’s disease: Evaluation of inflammatory activity using standard and cine-MR sequences. 94
Anti-TNF’s for prevention of postoperative recurrence of Crohn’s disease: The state of the art. 94
Totale 13.682
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.282
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.282
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.135 0 0 0 0 0 208 93 206 229 68 204 127
2021/20221.177 49 120 51 85 35 57 73 62 12 201 216 216
2022/20231.193 165 79 14 136 116 368 10 69 163 13 20 40
2023/2024276 51 29 12 2 50 50 4 21 38 2 7 10
2024/20252.685 29 171 81 38 211 183 199 192 289 242 339 711
2025/20262.283 267 529 382 375 672 58 0 0 0 0 0 0
Totale 16.724